{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:29:24Z","timestamp":1793316564985,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.jvir.2013.10.030","type":"journal-article","created":{"date-parts":[[2013,12,20]],"date-time":"2013-12-20T18:11:03Z","timestamp":1387563063000},"page":"297-306.e1","source":"Crossref","is-referenced-by-count":36,"title":["Pilot Study of Angiogenic Response to Yttrium-90 Radioembolization with Resin Microspheres"],"prefix":"10.1016","volume":"25","author":[{"given":"Darren R.","family":"Carpizo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekah H.","family":"Gensure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vyacheslav M.","family":"Gendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel J.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk F.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma K.","family":"Jabbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Nosher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2013.10.030_bib1","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvir.2013.10.030_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1200\/JCO.2004.09.046","article-title":"A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer","volume":"22","author":"Goldberg","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jvir.2013.10.030_bib3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/PPO.0b013e3181d7e8cf","article-title":"Radioembolization (yttrium-90 microspheres) for primary and metastatic hepatic malignancies","volume":"16","author":"Kennedy","year":"2010","journal-title":"Cancer J"},{"key":"10.1016\/j.jvir.2013.10.030_bib4","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.ijrobp.2005.09.011","article-title":"Selective internal radiation therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma","volume":"66","author":"Welsh","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jvir.2013.10.030_bib5","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.ijrobp.2004.09.004","article-title":"Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers","volume":"60","author":"Kennedy","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jvir.2013.10.030_bib6","series-title":"FOLFOX plus SIR-SPHERES MICROSPHERES versus FOLFOX alone in patients with liver mets from primary colorectal cancer (SIRFLOX)","author":"Gibbs","year":"2008"},{"key":"10.1016\/j.jvir.2013.10.030_bib7","unstructured":"Schonewolf CA, Patel B, Gensure RH, et al. Patterns of failure in colorectal patients with liver metastases after yttrium-90 radioembolization. Am J Clin Oncol. In press; available online December 27, 2012"},{"key":"10.1016\/j.jvir.2013.10.030_bib8","first-page":"3374","article-title":"Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation","volume":"59","author":"Gorski","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.jvir.2013.10.030_bib9","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s13277-011-0164-7","article-title":"Increase of angiogenic growth factors after hepatic artery embolization in patients with neuroendocrine tumours","volume":"32","author":"Korse","year":"2011","journal-title":"Tumour Biol"},{"key":"10.1016\/j.jvir.2013.10.030_bib10","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1111\/j.1349-7006.2008.00909.x","article-title":"Association between increment of serum VEGF level and prognosis after transcatheter arterial chemoembolization in hepatocellular carcinoma patients","volume":"99","author":"Shim","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jvir.2013.10.030_bib11","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.jvir.2011.08.017","article-title":"Changes in liver and spleen volumes and liver function after radioembolization with yttrium-90 resin microspheres","volume":"22","author":"Nosher","year":"2011","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2013.10.030_bib12","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/01.RVI.0000233785.75257.9A","article-title":"Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: technical and methodologic considerations","volume":"17","author":"Salem","year":"2006","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2013.10.030_bib13","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/01.RVI.0000235779.88652.53","article-title":"Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics","volume":"17","author":"Salem","year":"2006","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2013.10.030_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jvir.2010.10.029","article-title":"Research reporting standards for radioembolization of hepatic malignancies","volume":"22","author":"Salem","year":"2011","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2013.10.030_bib15","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrc1093","article-title":"Tumorigenesis and the angiogenic switch","volume":"3","author":"Bergers","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jvir.2013.10.030_bib16","first-page":"3121","article-title":"Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma","volume":"63","author":"Poon","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.jvir.2013.10.030_bib17","first-page":"386","article-title":"Association between vascular endothelial growth factor and metastasis after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma","volume":"3","author":"Xiong","year":"2004","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.jvir.2013.10.030_bib18","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1572-0241.2007.01712.x","article-title":"Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness","volume":"103","author":"Sergio","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jvir.2013.10.030_bib19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00000658-200102000-00012","article-title":"Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study","volume":"233","author":"Poon","year":"2001","journal-title":"Ann Surg"},{"key":"10.1016\/j.jvir.2013.10.030_bib20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.critrevonc.2010.10.005","article-title":"Trans-arterial chemoembolization as a therapy for liver tumours: new clinical developments and suggestions for combination with angiogenesis inhibitors","volume":"80","author":"Gadaleta","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jvir.2013.10.030_bib21","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrc2868","article-title":"Targeting the tumour vasculature: insights from physiological angiogenesis","volume":"10","author":"Chung","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jvir.2013.10.030_bib22","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm.2537","article-title":"Tumor angiogenesis: molecular pathways and therapeutic targets","volume":"17","author":"Weis","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.jvir.2013.10.030_bib23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.canlet.2012.08.018","article-title":"Angiopoietins in angiogenesis","volume":"328","author":"Fagiani","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jvir.2013.10.030_bib24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/jnci\/djs009","article-title":"Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis","volume":"104","author":"Holopainen","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jvir.2013.10.030_bib25","doi-asserted-by":"crossref","first-page":"11205","DOI":"10.1073\/pnas.172161899","article-title":"Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo","volume":"99","author":"Lobov","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jvir.2013.10.030_bib26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ccr.2010.07.001","article-title":"Double antiangiogenic protein, DAAP, targeting VEGF-A and angiopoietins in tumor angiogenesis, metastasis, and vascular leakage","volume":"18","author":"Koh","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jvir.2013.10.030_bib27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(12)61900-X","article-title":"Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial","volume":"381","author":"Grothey","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jvir.2013.10.030_bib28","series-title":"A phase 3, randomized, double-blind trial of weekly paclitaxel plus AMG 386 or placebo in women with recurrent partially platinum sensitive or resistant epithelial ovarian, primary peritoneal or fallopian tube cancers","year":"2013"},{"key":"10.1016\/j.jvir.2013.10.030_bib29","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1083\/jcb.153.3.543","article-title":"Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis","volume":"153","author":"Hellstr\u00f6m","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jvir.2013.10.030_bib30","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1101\/gad.266803","article-title":"Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall","volume":"17","author":"Lindblom","year":"2003","journal-title":"Genes Dev"},{"key":"10.1016\/j.jvir.2013.10.030_bib31","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1126\/science.1281554","article-title":"Interleukin-8 as a macrophage-derived mediator of angiogenesis","volume":"258","author":"Koch","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.jvir.2013.10.030_bib32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1200\/JCO.2009.22.4279","article-title":"Distinct patterns of cytokine and angiogenic factor modulation and markers of benefit for vandetanib and\/or chemotherapy in patients with non-small-cell lung cancer","volume":"28","author":"Hanrahan","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jvir.2013.10.030_bib33","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jvir.2013.01.494","article-title":"Treatment of hepatocellular carcinoma combining sorafenib and transarterial locoregional therapy: state of the science","volume":"24","author":"Weintraub","year":"2013","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2013.10.030_bib34","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1158\/1078-0432.CCR-12-2535","article-title":"Predictive impact of circulating vascular endothelial growth factor in four phase III trials evaluating bevacizumab","volume":"19","author":"Hegde","year":"2013","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044313015522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044313015522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T00:30:41Z","timestamp":1716337841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044313015522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S1051044313015522"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2013.10.030","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}